Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-02-27
1987-08-25
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514258, 514267, 514301, 514302, 514318, 544255, 544405, 546114, 546115, 546116, 546193, 546194, 546198, A61K 31445, C07D41714
Patent
active
046893300
ABSTRACT:
Novel substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines useful as anti-depressives, in the treatment of Parkinson's disease and in the treatment of diseases related with disturbed enterokinesia.
REFERENCES:
patent: 3953461 (1976-04-01), Denzel et al.
patent: 4224333 (1980-09-01), Clemence et al.
patent: 4342761 (1982-08-01), Ward
Wolff, M. (Editor), Burger's Medicinal Chemistry, Fourth Ed., Part III, Wiley Interscience, New York, 1980, pp. 943-944.
Boar Bernard R.
Janssens Frans E.
Stokbroekx Raymond A.
Van Offenwert Theophilus T. J. M.
Dellenbaugh Geoffrey G.
Janssen Pharmaceutica N.V.
Schwartz Richard A.
LandOfFree
Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923122